A Study Evaluating Pharmacodynamics, Pharmacokinetics, Safety and Tolerability of HSK3486 Single Bolus Dose Followed With a 30 Minute Constant Infusion in Healthy Male Subjects

NCT04029766 · clinicaltrials.gov ↗

PHASE1

Phase

COMPLETED

Status

13

Enrollment

INDUSTRY

Sponsor class

Conditions

Anesthesia
Sedation

Interventions

DRUG: HSK3486

Sponsor

Sichuan Haisco Pharmaceutical Group Co., Ltd